Multicenter study of weekly trastuzumab, paclitaxel and carboplatin followed by a week of rest every 28 days in patients with HER2+ metastatic breast cancer – incidence of central nervous system metastases
J. Salvador, M. Ruiz-Borrego, J. Bayo-Calero, M. Lomas-Garrido, A. Moreno-Vega, R. Bernabé, M. Valero, D. Vicente-Baz, J. Fuentes, A. López-LadrónVolume:
6
Year:
2008
Language:
english
DOI:
10.1016/s1359-6349(08)70726-2
File:
PDF, 73 KB
english, 2008